制定和稳定治疗性菌体:一篇综述
Eleni Siafakas1, Hien T T Duong2, Jonathan R Iredell3
1Sydney Pharmacy School, The University of Sydney, New South Wales, Australia; Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
International journal of antimicrobial agents
|February 27, 2026
概括
菌体 (菌体) 是一种有前途的抗生素替代品,但其不良的保质性阻碍了它们的使用. 本综述探讨了影响菌体活力的因素,旨在改善治疗应用的配方和储存.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 制药科学 制药科学
背景情况:
- 菌体 (菌体) 显示出对抗耐药细菌的抗生素替代品的潜力.
- 菌体治疗商业化目前的局限性源于菌体制剂的保质性不佳.
- 由于菌体的多样性和各种存储方法,缺乏标准化的配方方法.
研究的目的:
- 对影响治疗性菌体的保质性因素的现有文献进行审查.
- 识别菌体配方和稳定策略中的知识差距.
- 引导未来的研究,以改善菌体准备的寿命.
主要方法:
- 综合蛋白质和生物疗法配方数据的文献综述.
- 检查容器材料,缓冲器,盐/离子,pH值,温度,聚合物,表面活性剂和半固体配方的影响.
- 对菌体生存能力丧失机制的分析.
主要成果:
- 货架稳定性依赖于菌体,受到各种配方和储存参数的影响.
- 生命力丧失的机制包括表面吸附,体不稳定,聚合和结构/功能妥协.
- 诸如容器类型,pH值,温度和辅料等多种因素显著影响菌体的稳定性.
结论:
- 需要标准化配方协议来提高菌体治疗的临床可行性.
- 需要进行进一步的研究,以优化菌体稳定,以便大规模的治疗用途.
- 解决配方挑战对于实现菌体治疗的全部潜力至关重要.
相关概念视频
Lytic Cycle of Bacteriophages
78.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.6K
DNA Bacteriophages
1.2K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.2K
Lysogenic Cycle of Bacteriophages
68.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
68.3K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Viral Replication: Lysogenic Cycle
2.0K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
2.0K
Viral Replication: Lytic Cycle
2.0K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.0K


